Cover: Assessment of the implementation of the EU Drugs Strategy 2005—2012 and its Action Plans
Read Online

Assessment of the implementation of the EU Drugs Strategy 2005—2012 and its Action Plans

by Deirdre May Culley, Jirka Taylor, Jennifer Rubin, Stijn Hoorens, Emma Disley, Lila Rabinovich

Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 1.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Summary Only

FormatFile SizeNotes
PDF file 0.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Illicit drug use continues to be an important public health and safety concern in Europe. Production, trafficking and dealing in illicit drugs constitute important criminal justice challenges in themselves, and are associated with other criminal activities. The 2005-2012 EU Drugs Strategy (as with previous strategies) was developed to complement and add value to national strategies and approaches while respecting the principles of subsidiarity and proportionality set out in the EU Treaties. The main rationale for its development was that while drugs problems vary across Member States, and are experienced at the local and national level, they are "a global issue that needs to be addressed in a transnational context". RAND Europe undertook an independent evaluation of the current Strategy and its Action Plans, addressing four research objectives:

  1. To assess barriers and facilitators to the implementation of objectives and priorities at EU and Member State level
  2. To assess the relevance and influence of the Strategy with respect to national drugs policy and legislation
  3. To assess possible impact on the drugs situation in the EU
  4. To identify key aspects and recommendations for future EU Drugs Strategies

Table of Contents

  • Chapter One

    Introduction

  • Part One

    The EU Drugs Strategy and its context

    • Chapter Two

      Background to drugs policy in the EU

    • Chapter Three

      The EU Drugs Strategy 2005-2012

  • Part Two

    Assessment of the EU Drugs Strategy

    • Chapter Four

      Demand reduction

    • Chapter Five

      Supply reduction

    • Chapter Six

      Coordination

    • Chapter Seven

      International cooperation

    • Chapter Eight

      Information, research and evaluation

  • Part Three

    Synthesis

    • Chapter Nine

      Conclusions

    • Chapter Ten

      Recommendations

  • Appendix A

    Interview protocol – key informant interviews

  • Appendix B

    Interview protocol – EU level in-depth interviews

  • Appendix C

    Interview protocol – Member State level in-depth interviews

  • Appendix D

    Questions in the EEAS survey

  • Appendix E

    Findings from the EEAS survey

  • Appendix F

    Online questionnaire

  • Appendix G

    Case study objectives for implementation: data summary tables

  • Appendix H

    List of documents consulted

Research conducted by

The research described in this report was prepared for the European Commission Directorate General for Justice and conducted by RAND Europe.

This report is part of the RAND Corporation Technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.